Study finds low vitamin-d levels in northern California residents with metabolic syndrome

November 30, 2010

(SACRAMENTO, Calif.) ― Researchers from the UC Davis Health System have found that compared with healthy controls, blood levels of vitamin D are significantly reduced in patients in the Sacramento area with metabolic syndrome, a constellation of disease risk factors that affects about one in three U.S. adults and predisposes them to diabetes, heart disease and stroke.

The study is the first to examine vitamin-D status in patients with metabolic syndrome living in Northern California, where the many hours of sunshine make the vitamin-D deficiency finding surprising. The study, entitled "Low vitamin D levels in North American adults with the metabolic syndrome," was published online today and will appear in the January 2011 issue of the journal Hormone and Metabolic Research.

"In spite of our great sun exposure in Northern California, 30 percent of patients with metabolic syndrome have vitamin-D deficiency, and even many subjects in the control group had inadequate levels," said Ishwarlal Jialal, the study's principal investigator and professor of pathology and laboratory medicine at the UC Davis Health System. "Considering our climate and healthy lifestyles here, these findings were unexpected."

The study measured serum vitamin D levels in 44 people with metabolic syndrome and compared them to 37 healthy controls matched for age and gender. They found that 30 percent of subjects with metabolic syndrome were deficient in vitamin D compared with eight percent of controls. The difference between the groups was statistically significant and could not be explained by differences in sun exposure or other factors that are known to alter vitamin-D levels, such as kidney disease and amount of body fat. Furthermore, the low levels correlated with risk of diabetes such as insulin resistance and plasma glucose levels.

Metabolic syndrome has become highly prevalent in the United States with the obesity epidemic. The syndrome is characterized by having at least three of the following risk factors: a large waistline, a high blood-triglyceride level, a low-blood level of high-density lipoprotein (HDL) cholesterol, high-blood pressure and high-fasting blood sugar. These factors indicate disturbances in the body's metabolism, conferring at least a five-fold increased risk of developing diabetes and doubling the risk for developing cardiovascular diseases, including heart attack and stroke.

Vitamin D is a nutrient that has come under increased scrutiny in recent years as more of its roles in the human body are discovered. It has long been known to be important for healthy bone growth and maintaining normal calcium levels in the blood. More recent studies have also linked low vitamin-D levels to an increased risk of diabetes and cardiovascular disease as well as many cancers. Reduced vitamin D levels are also associated with higher fasting blood sugar, more insulin resistance and increased body fat, components of the metabolic syndrome.

Vitamin D is obtained naturally through sun exposure as well as through certain foods, including fish, liver and eggs. It can also be taken through supplements, and many dairy products, margarines and cereals are fortified with it. Although most people in California are traditionally thought to receive adequate vitamin D through routine outdoor activity, this study indicates that this is not the case in Northern California. A similar study recently conducted in Southern California found no difference in vitamin-D levels between subjects with and without metabolic syndrome, and in Florida, even diabetics do not tend to have low vitamin-D levels. These results indicate that vitamin D levels are probably adequate for most people living in those sunny latitudes, and that metabolic syndrome and diabetes arise mostly because of other factors in those areas.

"That our results were so different from the study undertaken in Southern California was amazing to us," said Jialal, who also serves as director of the Laboratory for Atherosclerosis and Metabolic Research at UC Davis. "The difference in latitude is not that great, but apparently sun exposure in southern California is adequate and in northern California it is not."

Controversy exists surrounding optimum blood levels of vitamin D. Current government guidelines for sufficient blood levels of vitamin D as well as daily intake are based on those required for bone health and are much lower than what are now believed by many experts to help prevent cancer, diabetes and cardiovascular disease. National Institutes of Health guidelines recommend a minimum blood level of 15 ng/mL as adequate for bone and overall health. However, many experts now feel that 30 to 100 ng/mL should be the goal. Levels above 150 ng/mL are potentially toxic and can be life-threatening.

In this study, vitamin D levels averaged 23.1 ng/mL among people with metabolic syndrome and 27.8 ng/mL in healthy controls, a difference that was found to be significant. Vitamin D deficiency in this study was defined as less than 20 ng/mL, and was found in 30 percent of subjects with metabolic syndrome and 8 percent of healthy controls. "Insufficiency" was defined as less than 30 ng/mL: 84 percent of the metabolic syndrome group and 67 percent of controls were found to have insufficient levels.

Jialal's team intends to continue to investigate the connections between vitamin D and metabolic syndrome. They plan to study diets of subjects with and without metabolic syndrome to determine whether vitamin D intake is adequate. According to Jialal, it is possible that people with metabolic syndrome have higher than average needs for vitamin D. Because the vitamin is fat-soluble, it tends to get sequestered in fat, making it less likely to circulate in the blood and to be available to other tissues.

They also plan to undertake a study on vitamin D supplementation for people with metabolic syndrome to see if it lowers fasting blood sugars and increases insulin sensitivity, trends that would lower the risk of developing diabetes.

"We have the potential to significantly delay or prevent the emergence of diabetes, heart attacks and strokes in people with metabolic syndrome through vitamin D supplementation," said Dr. Jialal. "This may offer a very simple yet powerful weapon to combat this burgeoning health problem in our society."
-end-
The other UC Davis study authors include Professor Sridevi Devaraj, student volunteer Ganesh Jialal and technologist Teri Cook measured the vitamin-D levels. David Siegel assisted in the study design and manuscript preparation. This study was supported by grants from the National Institutes of Health and American Diabetes Association.

University of California - Davis Health System

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.